Natural history of chronic hepatitis C in patients on hemodialysis: Case control study with 4-23 years of follow-up

World Journal of Gastroenterology

Volumn 10, Issue 15, 2004, Pages 2209-2212

  Okuda, Kunio ^a   Yokosuka, Osamu ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE CONTROL STUDY; CONTROLLED STUDY; DIALYSIS MEMBRANE; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HEPATITIS C; HUMAN; IMMUNOPATHOLOGY; KIDNEY CLEARANCE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; VIRUS PARTICLE;

EID: 4344718353     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i15.2209     Document Type: Article

References (24)

1. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000; 20: 1-16
2. Zeldis JB, Depner TA, Kuramoto IK, Gish RG, Holland OV. The prevalence of hepatitis C virus antibodies among hemodialysis patients. Ann Intern Med 1990; 112: 958-960
3. Okuda K, Hayashi H, Kobayashi S, Irie Y. Mode of hepatitis C infection not associated with blood transfusion among chronic hemodialysis patients. J Hepatol 1995; 23: 28-31
4. Zacks SL, Fried MW. Hepatitis B and C and renal failure. Infect Dis Clin North Am 2001; 15: 877-899
5. Sterling RK, Sanyal AJ, Luketic VA, Stravitz RT, King AL, Post AB, Mills AS, Contos MJ, Shiffman ML. Chronic hepatitis C infection in patients with end stage renal disease. Characterization of liver histology and viral load in patients awaiting renal transplantation. Am J Gastroenterol 1999; 94: 3576-3582
6. Stehman-Breen CO, Emerson S, Gretch D, Johnson RJ. Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 1998; 32: 629-534
7. Akoplat I, Ozyilkan E, Karagoz F, Akpolat T, Kandemie B. Hepatitis C in haemodialysis and nonuraemic patients: a histopathological study. Int Urol Nephrol 1998; 30: 349-355
8. Okuda K, Hayashi H, Yokozeki K, Kondo T, Kashima T, Irie Y. Interferon treatment for chronic hepatitis C in haemodialysis patients: suggestions based on a small series. J Gastroenterol Hepatol 1995; 10: 616-620
9. Murawaki Y, Ikuta Y, Koda M, Kawasaki H. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinase in patients with chronic viral liver disease: relation to liver histology. Hepatology 1994; 20: 780-787
10. Ishibashi K, Kashiwagi T, Ito A, Tanaka Y, Nagasawa M, Toyama T, Ozaki S, Naito M, Azuma M. Changes in serum fibrogenesis markers during interferon therapy for chronic hepatitis type C. Hepatology 1996; 24: 27-31
11. Wolf PL, Williams D, Coplon N, Coulson AS. Low aspratate transaminase activity in serum of patients undergoing hemodialysis. Clin Chim 1972; 18: 567-568
12. Yasuda K, Okuda K, Endo N, Ishiwatari Y, Ikeda R, Hayashi H, Yokozeki K, Kobayashi S, Irie Y. Hypoaminotransferasemia in patients undergoing long-term hemodialysis; clinical and biochemical appraisal. Gastroenterology 1995; 109: 1295-1300
13. Rehermann B. Interaction between the hepatitis C virus and tne immune system. Semin Liver Dis 2000; 20: 127-141
14. Ballardini G, Groff P, Pontisso P, Giostra F, Francesconi R, Lenzi M, Zauli D, Alberti A, Bianchi FB. Hepatitis C virus (HCV) genotype, tissue HCV antigens hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage, and response to interferon treatment in patients with chronic hepatitis C. J Clin Invest 1995; 95: 2067-2075
15. Decamps-Latscha B, Herbelin A. Long-term dialysis and cellular immunity: a critical survey. Kidney Int 1993; 43: S135-S142
16. Umlauft F, Gruenewald K, Weiss G, Kessler H, Urbanek M, Haun M, Santner B, Koenig P, Keeffe EB. Patterns of hepatitis C viremia in patients receiving hemodialysis. Am J Gastroenterol 1997; 92: 73-78
17. Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Vinson S, Mousa M, Gitnick G. Biological dynamics of viral load in hemodialysis patients with hepatitis C virus. Am J Kidney Dis 2000; 35: 122-129
18. Furusyo N, Hayashi J, Ariyama I, Sawayama Y, Etoh Y, Shigematsu M, Kashiwagi S. Maintenance hemodialysis decreases serum hepatitis C virus (HCV) RNA levels in hemodialysis patients with chronic HCV infection. Am J Gastroenterol 2000; 95: 490-496
19. Okuda K, Hayashi H, Yokozeki K, Irie Y. Destruction of hepatitis C virus particles by heamodialysis. Lancet 1996; 347: 909-910
20. Hayashi H, Okuda K, Yokosuka O, Kobayashi S, Yokozeki K, Ohtake Y, Irie Y. Adsorption of hepatitis C virus particles onto the dialyzer membrane. Artif Organs 1997; 21: 1056-1059
21. Janusz Kiewicz-Lewandonoska D, Wysocki J, Rembowska J, Lewandowski K, Nowak T, Pernak M, Nowak J. Hepatitis G virus co-infection may affect the elimination of hepatitis C virus RNA from the peripheral blood of hemodialysis patients. Acta Virol 2001; 45: 261-263
22. Okuda K, Kanda T, Yokosuka O, Hayashi H, Yokozeki K, Ohtake Y, Irie Y. GB virus-C infection among chronic haemodialysis patients: clinical implications. J Gastroenterol Hepatol 1997; 12: 766-770
23. Ikeuchi T, Okuda K, Yokosuka O, Kanda T, Kobayashi S, Murata M, Hayashi H, Yokozeki K, Ohtake Y, Kashima T, Irie Y. Superinfection of TT virus and hepatitis C virus among chronic haemodialysis patients. J Gastroenterol Hepatol 1999; 14: 796-800
24. Yokosuka O, Kojima H, Imazeki F, Tagawa M, Saisho H, Tamatsukuri S, Omata M. Spontaneous negativation of serum hepatitis C virus RNA is a rare event in type C chronic liver diseases: analysis of HCV RNA in 320 patients who were followed for more than 3 years. J Hepatol 1999; 31: 394-399